Trial Activity Snapshot: Did Australia’s “zero-Covid” plan protect clinical trial activity?
In an exclusive, Clinical Trials Arena dives into Australia’s trial activity data to find out how the pandemic impacted the…
By
Features (web)
Latest in
Features (web)
Revealed: the pharma companies best equipped with AI
Many untapped AI opportunities in clinical trials, considering companies mainly focus on drug discovery and repurposing.
By
Mapping Endpoints: How to build an ALS clinical trial
Differing endpoint and efficacy expectations can make designing an ALS clinical trial challenging. Clinical Trials Arena looks at ways to…
By
Twitter roundup: top five neurology tweets in Q3
Clinical Trial Arena lists five of the most popular tweets on neurology in Q3 2021 based on data from GlobalData’s…
Middle-income countries’ healthcare sectors to keep rising through to 2024
Healthcare provision markets of middle-income countries are set to climb at an average annual rate of 5.7% in the next…
By
SyneuRx to recruit 500–1,000 patients for oral Covid-19 antiviral Phase III test
The US-based Phase III will likely use electronic Patient Report Outcome (ePRO) tools to report symptoms.
By
Regulatory roundup: Invokana approval shot increases in heart failure with positive Phase III data
Merck KGaA in schistosomiasis and Jupiter Wellness in first-degree burns are also reviewed by GlobalData’s Investigative News team.
By
Eileen O’Reilly: how pancreatic cancer disease burden can stymie enrolment momentum
A dip in survival among pancreatic cancer patients is anticipated in the coming years due to the pandemic.
By